2CUREX.ST
Price:
$0.95
Market Cap:
$23.85M
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Industry
Biotechnology
IPO Date
2017-11-24
Stock Exchange
STO
Ticker
2CUREX.ST
According to 2cureX AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -2.26. This represents a change of 256.44% compared to the average of -0.63 of the last 4 quarters.
The mean historical PE Ratio of 2cureX AB (publ) over the last ten years is -34.51. The current -2.26 PE Ratio has changed 554.98% with respect to the historical average. Over the past ten years (40 quarters), 2CUREX.ST's PE Ratio was at its highest in in the December 2016 quarter at 30.41. The PE Ratio was at its lowest in in the December 2018 quarter at -79.01.
Average
-34.51
Median
-18.59
Minimum
-134.48
Maximum
-1.06
Discovering the peaks and valleys of 2cureX AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 104.37%
Maximum Annual PE Ratio = -1.06
Minimum Annual Increase = -82.66%
Minimum Annual PE Ratio = -134.48
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.16 | 104.37% |
| 2023 | -1.06 | -78.07% |
| 2022 | -4.81 | -66.96% |
| 2021 | -14.57 | -52.65% |
| 2020 | -30.76 | 53.99% |
| 2019 | -19.98 | -3.78% |
| 2018 | -20.76 | 20.60% |
| 2017 | -17.21 | -82.66% |
| 2016 | -99.27 | -26.18% |
The current PE Ratio of 2cureX AB (publ) (2CUREX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.68
5-year avg
-10.67
10-year avg
-34.51
2cureX AB (publ)’s PE Ratio is less than Guard Therapeutics International AB (publ) (-0.24), less than Qlife Holding AB (publ) (-0.57), less than Modus Therapeutics Holding AB (publ) (-1.16), less than Fluicell AB (publ) (-1.81), greater than ODI Pharma AB (-5.18), less than Stayble Therapeutics AB (publ) (-1.95), less than Aptahem AB (publ) (-2.26), less than Episurf Medical AB (publ) (-0.48), less than Prostatype Genomics AB (publ) (-0.21), less than LIDDS AB (publ) (-1.69),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.24 | $28.03M | |
| -0.57 | $19.48M | |
| -1.16 | $33.73M | |
| -1.81 | $14.56M | |
| -5.18 | $30.98M | |
| -1.95 | $16.38M | |
| -2.26 | $16.98M | |
| -0.48 | $21.93M | |
| -0.21 | $20.77M | |
| -1.69 | $6.69M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 2cureX AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 2cureX AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 2cureX AB (publ)'s PE Ratio?
How is the PE Ratio calculated for 2cureX AB (publ) (2CUREX.ST)?
What is the highest PE Ratio for 2cureX AB (publ) (2CUREX.ST)?
What is the 3-year average PE Ratio for 2cureX AB (publ) (2CUREX.ST)?
What is the 5-year average PE Ratio for 2cureX AB (publ) (2CUREX.ST)?
How does the current PE Ratio for 2cureX AB (publ) (2CUREX.ST) compare to its historical average?